Integras Partners’s Johnson & Johnson JNJ Stock Holding History

Integras Partners’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-15,658	Closed	-$2.26M	–	63
2024 Q4	$2.26M	Buy	+15,658	New	+$2.43M	1.93%	26

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Integras Partners's JNJ Position: Q1 2025 in Review

Integras Partners sold out of Johnson & Johnson (JNJ) in Q1 2025, closing a stake of 15,658 shares — an estimated $2.26M sold.

Integras Partners first reported a position in JNJ in Q4 2024 and held it in 1 quarter. The position peaked at $2.26M in Q4 2024. 4,147 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

Integras Partners reported no remaining Johnson & Johnson position as of Q1 2025 after selling out during the quarter.
Integras Partners sold 15,658 Johnson & Johnson shares in Q1 2025, an estimated $2.26M.
Integras Partners first reported a position in Johnson & Johnson in Q4 2024 and held it in 1 quarter.
Integras Partners's Johnson & Johnson position peaked at $2.26M in Q4 2024.
4,147 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Integras Partners's 13F filing for Q1 2025, filed 14 May 2025.